Medpace published its latest edition of Seamless Clinical Insights exploring key strategies to drive innovation and success in sepsis clinical development, including disease heterogeneity, patient recruitment, data quality, and microbiology analysis.
Public source
Publisher name
Public post
#Sepsis remains a significant global health challenge, affecting nearly 49 million people annually. During Sepsis Awareness Month, Medpace highlights the importance of a…
Company
Medpace
Accelerating Drug, Biologic and Medical Device Clinical Development
- Industry
- Pharmaceutical Manufacturing
- Location
- Cincinnati, US
- Company size
- 5,001–10,000 employees
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people across 46 countries.
See moreLatest activity
Latest activity from Medpace
9 signals
Presence & Recognition
Medpace has been named a finalist for the 2026 Society for Clinical Research Sites (SCRS) Eagle Award
Research & Knowledge
Medpace executed a case study on Duchenne Muscular Dystrophy clinical trials, highlighting how Medpace executes DMD trials seamlessly.
Presence & Recognition
Medpace Poland team competed in their annual office park volleyball tournament and took home first place
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Parexel
Parexel experts published a case study in the New Medicines Novel Insights newsletter discussing how scientific planning, operational readiness, and stakeholder alignment helped a multinational sponsor execute a complex clinical pharmacology study in China.
Research & Knowledge
Uniphar | Clinical
Uniphar | Clinical published a guide from Uniphar | Development sharing practical insights to help sponsors master FDA engagement and keep programs progressing.
Research & Knowledge
BAP Pharma
BAP Pharma published a case study detailing how the company helped a sponsor overcome increased demand, compressed packaging timelines, procurement constraints, and product waste risk through an agile comparator sourcing strategy.
Research & Knowledge
Quotient Sciences
Quotient Sciences published a Q&A by Iain Shaw discussing how human ADME study design is changing in practice following the FDA's 2024 guidance.
Research & Knowledge
Alcura